Gw&K Investment Management, LLC Oncocyte Corp Transaction History

Gw&K Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.04 - $3.59 $1.59 Million - $2.81 Million	-781,789 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$3.53 - $5.89 $15,355 - $25,621	4,350 Added 0.56%	781,789 $2.78 Million
Q1 2021 May 11, 2021	BUY	$2.39 - $6.5 $1.86 Million - $5.05 Million	777,439 New	777,439 $4.04 Million

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $326M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.